A monitoring protocol can detect intraocular inflammation early and enable favorable visual outcomes in patients being treated for AMD.

Pykus Therapeutics reveals promising results for PYK-2101, a retinal sealant that enhances recovery and improves patient ...

The trial aims to assess the tolerability and safety of the sealant within the first 16 weeks after pars plana vitrectomy.

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company advancing innovative treatments targeting the ...

Verana Health’s newly launched Qdata Cataract offers a comprehensive dataset to improve outcomes, reduce complications and ...

Background Due to technical limitations of commonly used tonometry devices, the effects of physical exercise on intraocular ...

Gland Pharma has received USFDA approval for its generic Latanoprostene Bunod Ophthalmic Solution, intended to treat high eye ...

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

More information: Rachel K. Casemore et al, A prospective, longitudinal study to assess progression of ocular surface signs, ...

Frequent headaches behind your eyes could signal more than stress? From eye strain to glaucoma, your eyes might be trying to ...

Current diagnostic procedures for AD are both costly and highly invasive for patients. Age-related cataract (ARC), a common ocular condition in elderly populations, correlates with a 1.43-fold ...